Orthofix International N.V., a medical device company, provides musculoskeletal healing products and value-added services worldwide. It operates through four segments: BioStim, Extremity Fixation, Spine Fixation, and Biologics. The BioStim segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures. The Extremity Fixation segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The Spine Fixation segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. Orthofix International N.V. was founded in 1987 and is headquartered in Lewisville, Texas.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:OFIX
CUSIPN6748L10
Phone599-9-4658525
Debt
Debt-to-Equity RatioN/A
Current Ratio4.04
Quick Ratio2.85
Price-To-Earnings
Trailing P/E Ratio36.81
Forward P/E Ratio36.14
P/E Growth3.62
Sales & Book Value
Annual Sales$433.82 million
Price / Sales2.59
Cash Flow$2.9164 per share
Price / Cash20.57
Book Value$16.23 per share
Price / Book3.70
Profitability
EPS (Most Recent Fiscal Year)$1.62
Net Income$6.22 million
Net Margins3.21%
Return on Equity11.08%
Return on Assets8.28%
Miscellaneous
Employees858
Outstanding Shares18,760,000
Market Cap$1,095.03
Orthofix International (NASDAQ:OFIX) Frequently Asked Questions
What is Orthofix International's stock symbol?
Orthofix International trades on the NASDAQ under the ticker symbol "OFIX."
How were Orthofix International's earnings last quarter?
Orthofix International NV (NASDAQ:OFIX) released its quarterly earnings results on Monday, April, 30th. The medical device company reported $0.39 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.03. The medical device company earned $108.71 million during the quarter, compared to analysts' expectations of $107.10 million. Orthofix International had a return on equity of 11.08% and a net margin of 3.21%. Orthofix International's quarterly revenue was up 5.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.27 EPS. View Orthofix International's Earnings History.
When is Orthofix International's next earnings date?
What guidance has Orthofix International issued on next quarter's earnings?
Orthofix International updated its FY18 earnings guidance on Monday, April, 30th. The company provided earnings per share (EPS) guidance of $1.58-1.68 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.62. The company issued revenue guidance of $458-464, compared to the consensus revenue estimate of $460.20 million.Orthofix International also updated its Q2 guidance to $0.35-0.37 EPS.
What price target have analysts set for OFIX?
5 analysts have issued 1 year target prices for Orthofix International's shares. Their forecasts range from $55.00 to $67.00. On average, they anticipate Orthofix International's share price to reach $60.00 in the next year. This suggests that the stock has a possible downside of 0.1%. View Analyst Ratings for Orthofix International.
What is the consensus analysts' recommendation for Orthofix International?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix International in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
Who are some of Orthofix International's key competitors?
Some companies that are related to Orthofix International include Cantel Medical (CMD), Novocure (NVCR), Merit Medical Systems (MMSI), NuVasive (NUVA), Irhythm Technologies (IRTC), Nevro (NVRO), Mazor Robotics (MZOR), Luminex (LMNX), Glaukos (GKOS), Tandem Diabetes Care (TNDM), Cardiovascular Systems (CSII), Atrion (ATRI), Cryolife (CRY), Intersect ENT (XENT) and OraSure Technologies (OSUR).
Who are Orthofix International's key executives?
Orthofix International's management team includes the folowing people:
- Mr. Bradley R. Mason, Pres, CEO & Director (Age 64)
- Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 52)
- Ms. Kimberley A. Elting, Chief Legal & Admin. Officer (Age 53)
- Mr. Michael M. Finegan, Chief Strategy Officer (Age 54)
- Mr. Davide Bianchi, Pres of Global Extremity Fixation (Age 53)
Has Orthofix International been receiving favorable news coverage?
Media coverage about OFIX stock has trended somewhat positive this week, Accern reports. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Orthofix International earned a news impact score of 0.17 on Accern's scale. They also assigned news articles about the medical device company an impact score of 45.92 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.
Who are Orthofix International's major shareholders?
Orthofix International's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Bank of Montreal Can (0.18%), Municipal Employees Retirement System of Michigan (0.03%) and Hartford Investment Management Co. (0.03%). Company insiders that own Orthofix International stock include Brad Mason, Bradley V Niemann, Davide Bianchi, Luke T Faulstick, Michael Finegan, Raymond Fujikawa, Rice Doug and Ronald A Matricaria. View Institutional Ownership Trends for Orthofix International.
Which institutional investors are selling Orthofix International stock?
OFIX stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can and Municipal Employees Retirement System of Michigan. Company insiders that have sold Orthofix International company stock in the last year include Brad Mason, Bradley V Niemann, Davide Bianchi, Luke T Faulstick, Raymond Fujikawa and Rice Doug. View Insider Buying and Selling for Orthofix International.
Which institutional investors are buying Orthofix International stock?
How do I buy shares of Orthofix International?
Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Orthofix International's stock price today?
One share of OFIX stock can currently be purchased for approximately $60.05.
How big of a company is Orthofix International?
Orthofix International has a market capitalization of $1.10 billion and generates $433.82 million in revenue each year. The medical device company earns $6.22 million in net income (profit) each year or $1.62 on an earnings per share basis. Orthofix International employs 858 workers across the globe.
How can I contact Orthofix International?
Orthofix International's mailing address is 7 ABRAHAM DE VEERSTRAAT, WILLEMSTAD P8, . The medical device company can be reached via phone at 599-9-4658525 or via email at [email protected]
MarketBeat Community Rating for Orthofix International (NASDAQ OFIX)
MarketBeat's community ratings are surveys of what our community members think about Orthofix International and other stocks. Vote "Outperform" if you believe OFIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OFIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
